GB201908232D0 - Combination Therapy - Google Patents

Combination Therapy

Info

Publication number
GB201908232D0
GB201908232D0 GBGB1908232.0A GB201908232A GB201908232D0 GB 201908232 D0 GB201908232 D0 GB 201908232D0 GB 201908232 A GB201908232 A GB 201908232A GB 201908232 D0 GB201908232 D0 GB 201908232D0
Authority
GB
United Kingdom
Prior art keywords
combination therapy
therapy
combination
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1908232.0A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
ADC Therapeutics SA
MedImmune Ltd
Original Assignee
ADC Therapeutics SA
MedImmune Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ADC Therapeutics SA, MedImmune Ltd filed Critical ADC Therapeutics SA
Priority to GBGB1908232.0A priority Critical patent/GB201908232D0/en
Publication of GB201908232D0 publication Critical patent/GB201908232D0/en
Priority to EP20733375.8A priority patent/EP3980078A1/en
Priority to CN202080043019.8A priority patent/CN114302746A/en
Priority to PCT/EP2020/065879 priority patent/WO2020249527A1/en
Priority to JP2021573163A priority patent/JP2022536140A/en
Priority to AU2020289961A priority patent/AU2020289961A1/en
Priority to MX2021015401A priority patent/MX2021015401A/en
Priority to SG11202113293XA priority patent/SG11202113293XA/en
Priority to CA3142664A priority patent/CA3142664A1/en
Priority to KR1020227000168A priority patent/KR20220020331A/en
Priority to IL288717A priority patent/IL288717A/en
Ceased legal-status Critical Current

Links

GBGB1908232.0A 2019-06-10 2019-06-10 Combination Therapy Ceased GB201908232D0 (en)

Priority Applications (11)

Application Number Priority Date Filing Date Title
GBGB1908232.0A GB201908232D0 (en) 2019-06-10 2019-06-10 Combination Therapy
KR1020227000168A KR20220020331A (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-CD25 antibody drug conjugate and an additional agent
JP2021573163A JP2022536140A (en) 2019-06-10 2020-06-08 combination therapy
CN202080043019.8A CN114302746A (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-CD 25 antibody drug conjugate and another agent
PCT/EP2020/065879 WO2020249527A1 (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent
EP20733375.8A EP3980078A1 (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent
AU2020289961A AU2020289961A1 (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-CD25 antibody drug conjugate and a further agent
MX2021015401A MX2021015401A (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent.
SG11202113293XA SG11202113293XA (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent
CA3142664A CA3142664A1 (en) 2019-06-10 2020-06-08 Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent
IL288717A IL288717A (en) 2019-06-10 2021-12-06 Combination therapy comprising an anti-cd25 antibody drug conjugate and a further agent

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1908232.0A GB201908232D0 (en) 2019-06-10 2019-06-10 Combination Therapy

Publications (1)

Publication Number Publication Date
GB201908232D0 true GB201908232D0 (en) 2019-07-24

Family

ID=67386095

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1908232.0A Ceased GB201908232D0 (en) 2019-06-10 2019-06-10 Combination Therapy

Country Status (1)

Country Link
GB (1) GB201908232D0 (en)

Similar Documents

Publication Publication Date Title
IL277336A (en) Combination therapy
GB201804255D0 (en) Macrophage-based therapy
GB201900702D0 (en) Therapy
IL280968A (en) Combination therapy
IL279908A (en) Combination therapy
IL288237A (en) Combination therapy
GB201912191D0 (en) New therapy
IL280729A (en) Combination therapy
GB201906864D0 (en) Combination therapy
ZA202200731B (en) Combination therapy
GB201919301D0 (en) Combination therapy
GB201917254D0 (en) Combination therapy
GB201914006D0 (en) Combination Therapy
GB201910473D0 (en) Combination therapy
GB201908225D0 (en) Combination therapy
GB201908234D0 (en) Combination therapy
GB201908227D0 (en) Combination therapy
GB201908231D0 (en) Combination therapy
GB201908232D0 (en) Combination Therapy
GB201908233D0 (en) Combination therapy
GB201906867D0 (en) Combination therapy
GB201906862D0 (en) Combination therapy
GB201906873D0 (en) Combination therapy
IL264410A (en) Combination therapy
GB201919036D0 (en) Therapy

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)